Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLCPreparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines
/in International Publications, Ovarian CancerMannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsHeat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
/in Colorectal Cancer, International PublicationsNovel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
/in Chronic Virus Hepatitis, International PublicationsImmunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
/in Dendritic Cells, International PublicationsDacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
/in International Publications, Malignant MelanomaImmature dendritic cell-derived exosomes can mediate HIV-1 trans infection
/in HIV/AIDS, International PublicationsDendritic cell defects in patients with cancer: mechanisms and significance
/in Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer